ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,747, issued on June 3, was assigned to MEDICOVESTOR INC. (Wilmington, Del.).
"Methods of using anti-SP17 immunotherapeutics" was invented by Seah Lim (Wilmington, Del.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure describes proteins that specifically bind human sperm protein 17 (Sp17) with nanomolar affinity and high specificity. These proteins include a recombinant human anti-Sp17 IgG that is suitable for use as a therapeutic antibody to treat cancers that ectopically express Sp17. Other Sp17-binding proteins are described including antibody fragments, antibody conjugates, and fusion proteins."
The patent was filed on Jan. 9, 2024,...